Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
about
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Comparison of the adverse even ...... dverse event reporting system.
@en
type
label
Comparison of the adverse even ...... dverse event reporting system.
@en
prefLabel
Comparison of the adverse even ...... dverse event reporting system.
@en
P2093
P2860
P1433
P1476
Comparison of the adverse even ...... adverse event reporting system
@en
P2093
Akiho Fukuda
Haruna Hatahira
Hirofumi Takeuchi
Kohei Tahara
Misa Naganuma
Satoshi Nakao
Sayaka Sasaoka
Shiori Hasegawa
Toshinobu Matsui
P2860
P304
P356
10.1371/JOURNAL.PONE.0185654
P407
P577
2017-09-27T00:00:00Z